ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Ukr125
|
152 |
45K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
45K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Option Holders as at 29/12/2020 with only one variation.variations.
|
|
Ukr125
|
64 |
17K |
7 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
64
|
17K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
Ukr125
|
97 |
21K |
2 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
97
|
21K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
Ukr125
|
97 |
21K |
4 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
97
|
21K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update
|
|
Ukr125
|
37 |
8.9K |
10 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
37
|
8.9K
|
10
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: West Arunta Project - High Grade Nb-Ta in Weathered Zone
|
|
Ukr125
|
347 |
113K |
2 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
347
|
113K
|
2
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
6 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
2.6K
|
817K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD
|
|
Ukr125
|
153 |
40K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
153
|
40K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Ukr125
|
1.4K |
368K |
4 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
1.4K
|
368K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Ukr125
|
1.4K |
368K |
4 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
1.4K
|
368K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Ukr125
|
1.4K |
368K |
2 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
1.4K
|
368K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Completes Enrolment of First Patient Cohort
|
|
Ukr125
|
98 |
21K |
11 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
98
|
21K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD
|
|
Ukr125
|
153 |
40K |
3 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
153
|
40K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Ukr125
|
1.4K |
368K |
5 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
1.4K
|
368K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Ukr125
|
1.4K |
368K |
2 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
1.4K
|
368K
|
2
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
1 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
1
|
|
ASX - By Stock
|
OVT |
Re:
Ann: ********* Presentation
|
|
Ukr125
|
25 |
8.7K |
0 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
25
|
8.7K
|
0
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
0 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Ukr125
|
207 |
46K |
2 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
207
|
46K
|
2
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: Suspension from Official Quotation
|
|
Ukr125
|
171 |
69K |
0 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
171
|
69K
|
0
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: Trading Halt
|
|
Ukr125
|
174 |
65K |
1 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
174
|
65K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Ukr125
|
207 |
46K |
4 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
207
|
46K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Ukr125
|
207 |
46K |
6 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
207
|
46K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Ukr125
|
207 |
46K |
2 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
207
|
46K
|
2
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: West Arunta Project - Discovery of a Mineralised Carbonatite
|
|
Ukr125
|
868 |
377K |
4 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
868
|
377K
|
4
|
|
ASX - By Stock
|
OVT |
Re:
Ann: IOU Announces SPP Launch, Booklet & Timetable
|
|
Ukr125
|
74 |
29K |
1 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
74
|
29K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Ukr125
|
207 |
46K |
7 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
207
|
46K
|
7
|
|
ASX - By Stock
|
FLT |
Re:
Ann: FLT 2022 AGM Presentation
|
|
Ukr125
|
15 |
9.8K |
1 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
15
|
9.8K
|
1
|
|
ASX - By Stock
|
FLT |
Re:
Ann: FLT 2022 AGM Presentation
|
|
Ukr125
|
15 |
9.8K |
1 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
15
|
9.8K
|
1
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
0 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
0
|
|
ASX - By Stock
|
OVT |
Re:
Ann: IOUpay Signs Strategic Partnership Agreement with IDSB
|
|
Ukr125
|
135 |
35K |
1 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
135
|
35K
|
1
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
0 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
0
|
|
ASX - By Stock
|
OVT |
Re:
Ann: IOUpay Signs Strategic Partnership Agreement with IDSB
|
|
Ukr125
|
135 |
35K |
2 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
135
|
35K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
Ukr125
|
54 |
9.5K |
3 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
54
|
9.5K
|
3
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
1 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
1
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
4 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
4
|
|
ASX - By Stock
|
OVT |
Re:
Ann: IOUpay Signs Strategic Partnership Agreement with IDSB
|
|
Ukr125
|
135 |
35K |
3 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
135
|
35K
|
3
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
4 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
4
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
3
|
|
ASX - By Stock
|
WA1 |
Re:
WA1 Share Price
|
|
Ukr125
|
2.6K |
817K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
2.6K
|
817K
|
3
|
|
ASX - By Stock
|
WA1 |
Re:
Ann: West Arunta Project - Discovery of a Mineralised Carbonatite
|
|
Ukr125
|
868 |
377K |
1 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
868
|
377K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
Ukr125
|
92 |
19K |
7 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
92
|
19K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Ukr125
|
240 |
110K |
5 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
240
|
110K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
Ukr125
|
216 |
46K |
4 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
216
|
46K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Ukr125
|
10K |
4.7M |
0 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
10K
|
4.7M
|
0
|
|
ASX - By Stock
|
FLT |
Re:
Ann: FLT FY22 FULL YEAR RESULTS PRESENTATION
|
|
Ukr125
|
12 |
8.1K |
1 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
12
|
8.1K
|
1
|
|
ASX - By Stock
|
ANZ |
Re:
Ann: ANZ completes Institutional Entitlement Offer
|
|
Ukr125
|
179 |
92K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
179
|
92K
|
0
|
|
ASX - By Stock
|
ANZ |
Re:
Ann: ANZ completes Institutional Entitlement Offer
|
|
Ukr125
|
179 |
92K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
179
|
92K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Ukr125
|
10K |
4.7M |
2 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
Ukr125
|
46K |
11M |
0 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
46K
|
11M
|
0
|
|